SS 35 - SBRT for Pancreaticobiliary Cancer, a SOFT Hand or a Lethal Blow?

Presentations

• 02:15pm - 02:25pm ET

  A Randomized, Phase II Clinical Trial of Stereotactic Body Radiation Therapy Or Conventionally Fractionated Concurrent Chemotherapy and Radiation Therapy Preoperatively for Pancreatic Adenocarcinoma, the SOFT Preop Study

  Speaker: William Hall, MD - Medical College of Wisconsin, Milwaukee
• 02:25pm - 02:35pm ET

  Primary and Retrospective Analysis of GRECO-2: A Randomized, Double-Blind, Placebo-Controlled Phase II Trial of SABR ± Rucosopasem in Localized Pancreatic Cancer

  Speaker: Todd Aguilera, MD, PhD - UT Southwestern Medical Center, Dallas
• 02:35pm - 02:45pm ET

  Stereotactic Body Radiation Therapy vs. Radiofrequency Ablation for Small (=2 cm) HCCs: Interim Results from a Prospective, Single-Center, Non-Inferiority Randomized Clinical Trial (ChiCTR2000039404)

  Speaker: Lihong Wang, - Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
• 02:45pm - 02:55pm ET

  Prospective Study of Combined Stereotactic Body Radiotherapy and Immunotherapy in Locally Advanced Hepatocellular Carcinoma - Five-Year Survival Update

  Speaker: Chi Leung Chiang, MD, MB, ChB - University of Hong Kong, Hong Kong
• 02:55pm - 03:05pm ET

  A Randomized Phase II Study of Hypofractionated Stereotactic Radiotherapy With Concurrent 5-FU/Capecitabine With or Without Zoledronic Acid in Locally Advanced Pancreatic Ductal Adenocarcinoma

  Speaker: Chi Lin, MD, PhD, MS - University of Nebraska Medical Center, Omaha
• 03:05pm - 03:15pm ET

  Planning, Delivery and Safety of Dose-Escalated Radiation in GRECO2: Secondary Analysis of a Large International Randomized Trial for Localized Pancreatic Cancer

  Speaker: Ryan Kuehnle, MD - JPS Health, Fort Worth
• 03:15pm - 03:25pm ET

  Discussant

  Speaker: Michael Chuong, MD - Miami Cancer Institute at Baptist Health South Florida, Miami